Ivan Hernandez

Ivan Hernandez is a Global Study Manager at Labcorp Drug Development, bringing over a decade of experience in academic research and biotechnology. They hold a PhD and Bachelor's degree in Molecular Biology, with a strong focus on cardiovascular and renal fields, specifically diabetes and hypertension. Previously, they served as a Research Fellow at UCL and the University of Birmingham, and held roles at King's College London and Axovia Therapeutics, where they specialized in gene therapy. Ivan is committed to leveraging their scientific expertise to enhance patient outcomes in the pharmaceutical industry.